Aelis Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook
2023 has been marked by key milestones for the Company’s two drug candidates:
AEF0117: completion of patient recruitment for the phase 2b study with 333 patients in excessive cannabis use disorders
…